Skip to NavigationSkip to content

top 10

Top Ten most popular articles on Pharmafile.com this week

The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is not safe to relax social distancing rules for indoor settings in England, while Germany’s coronavirus R number has drastically increased.

Top Ten most popular articles on Pharmafile.com this week

The news this week centres around COVID-19 vaccines, as Moderna is to start testing 30,000 people with its vaccine beginning in July, while Sanofi has announced it will funnel €610 million into a new project to build a new vaccine manufacturing facility and research site in its home country of France. Beijing-based firm Sinovac has revealed new Phase 1/2 data on its own COVID-19 vaccine, known as CoronaVac.

Top Ten most popular articles on Pharmafile.com this week

The news this week continues to be dominated by breakthroughs in COVID-19 treatments, with a US clinical trial of the drug ivermectin finding that it reduced the mortality rate of COVID-19 patients by 40%, while an antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its chief scientists.

Pharmafile.com's weekly COVID-19 news round-up

Photo by CDC

Hydroxychloroquine as a potential coronavirus treatment continues to be a contentious issue, as a new study led by researchers at the University of Minnesota finds it does not protect people from COVID-19, while The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was dangerous for use in COVID-19 patients.

Top Ten most popular articles on Pharmafile.com this week

GlaxoSmithKline features prominently in the news this week, as they pledged to pay a cash bonus of £1,500 to staff continuing to work during the COVID-19 pandemic but this did not include their cleaners, while the company also has committed to the manufacture and distribution of one billion doses of vaccine adjuvant against COVID-19 throughout 2021.

Top Ten most popular articles on Pharmafile.com this week

The news this week continues to be dominated by COVID-19 vaccines and treatments, with the NIAID announcing the launch of a second remdesivir trial while French based Sanofi announced it will ship COVID-19 vaccine to the US first. The FDA has also granted Fast Track designation for Moderna’s coronavirus vaccine candidate.

In other news, 100% of multiple myeloma patients responded to Janssen's investigational CAR T therapy while Eli Lilly’s Retevmo was approved by FDA to treat lung and thyroid cancers.

Top Ten most popular articles on Pharmafile.com this week

Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while the FDA and Novartis have agreed to conduct a similar Phase 3 trial with the drug. Meanwhile, experts at the US National Institutes of Health (NIH) have drafted treatment guidelines for the use of hydroxychloroquine in COVID-19 patients, saying it should not be used due to “potential toxicities.”

Top Ten most popular articles on Pharmafile.com this week

Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the drug does not speed up the recovery of coronavirus while another in Brazil was suspended after 11 patients died after taking the anti-malaria treatment. 

President Trump has continually touted it as a treatment for the virus, and there has been an increase in people abusing the drug. 

Top Ten most popular articles on Pharmafile.com this week

This week nasal sprays based on illegal recreational drugs feature prominently, as the FDA has moved to approve Lannett Company’s Numbrino (cocaine hydrochloride) nasal solution for the introduction of local anaesthesia of the mucous membranes for diagnostic procedures and surgeries. This is contrary to NICE in the UK which rejected Janssen’s Spravato (esketamine) nasal spray, derived from the party drug ketamine, for use in England and Wales for treatment-resistant depression.

Top Ten most popular articles on Pharmafile.com this week

Happy Friday! It's time for another rundown of the top 10 most popular articles with Pharmafile.com readers this week.

10. NICE Chief Sir Andrew Dillon to step down in 2020

It’s the end of an era at NICE as its Chief Executive Sir Andrew Dillon announces that he will step down from his role at the end of March next year.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches